EcoR1 Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
10
- Investments
-
146
- Portfolio
-
25
- Exits
-
88
EcoR1 Capital General Information
Company Description
Founded in 2013, EcoR1 Capital is a venture capital firm based in San Francisco, California. The firm seeks to invest in the biotech sector. This firm is a Registered Investment Adviser (RIA).
Business Details
Website
www.ecor1cap.comYear Founded
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- 357 Tehama Street
- Floor 3
- San Francisco, CA 94103
- United States
EcoR1 Capital Investments (146)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Setara Biosciences | 30-Oct-2026 | Early Stage VC | Biotechnology | Clinical Trials - Phase 1 | ||
| Gossamer Bio | 24-Aug-2026 | Drug Discovery | Generating Revenue | |||
| Artiva Biotherapeutics | 08-May-2026 | Drug Discovery | Generating Revenue | |||
| Immunic Therapeutics | 17-Feb-2026 | Drug Discovery | Generating Revenue | |||
| Diagonal Therapeutics | 08-Jan-2026 | Drug Discovery | Product Development | |||
| Attovia Therapeutics | 30-Mar-2025 | Drug Discovery | Generating Revenue/Not Profitable | |||
| Tectonic Therapeutic | 03-Feb-2025 | Drug Discovery | Generating Revenue | |||
| Attovia Therapeutics | 21-Jan-2025 | Drug Discovery | Generating Revenue/Not Profitable | |||
| Neurogene | 05-Nov-2024 | PIPE | Drug Discovery | Generating Revenue/Not Profitable | ||
| Aktis Oncology | 20-Sep-2024 | Early Stage VC | Drug Discovery | Generating Revenue |
EcoR1 Capital Exits (88)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Actio Biosciences | 15-Sep-2026 | Merger/Acquisition | |
| Cyclerion | 08-Sep-2026 | ||
| Attovia Therapeutics | 05-Aug-2026 | ||
| Freenome | 20-Jul-2026 | ||
| Neurogene | 02-Jul-2026 | ||
| Ajax Therapeutics | 13-Jun-2026 | ||
| Tango Therapeutics | 09-Jun-2026 | ||
| Paratus Diagnostics | 26-Apr-2026 | ||
| Ventyx Biosciences | 04-Mar-2026 | Merger/Acquisition | |
| Eikon Therapeutics | 05-Feb-2026 | IPO |
EcoR1 Capital Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
EcoR1 Capital Co-Investors (137)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Timefolio Capital | 4 |
|
|
||
| Vida Ventures (Los Angeles) |
|
|
|||
| Atlas Venture |
|
|
|||
| Frazier Healthcare Partners |
|
|
|||
| MPM BioImpact |
|
|
EcoR1 Capital FAQs
-
What is EcoR1 Capital?
Founded in 2013, EcoR1 Capital is a venture capital firm based in San Francisco, California.
-
When was EcoR1 Capital founded?
EcoR1 Capital was founded in 2013.
-
Where is EcoR1 Capital headquartered?
EcoR1 Capital is headquartered in San Francisco, CA.
-
What is EcoR1 Capital's total asset value?
EcoR1 Capital has around in total assets under management.
-
How many investments has EcoR1 Capital made?
EcoR1 Capital has made 146 investments.
-
What has EcoR1 Capital invested in?
EcoR1 Capital has made numerous investments in companies like Setara Biosciences, Gossamer Bio, and Artiva Biotherapeutics within the Biotechnology and Drug Discovery industries.
-
What has EcoR1 Capital invested in recently?
EcoR1 Capital's latest investment was on 30-Oct-2026 in Setara Biosciences, a company within the Biotechnology industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
